Showing results (211-220 of 1,074) with videos related to

Sort By:
Pageof 108
Therapeutic Advances in Neurological Disorders|December 30, 2024
Intrinsic brain activity differences in drug-resistant epilepsy and well-controlled epilepsy patients: an EEG microstate analysisChaofeng Zhu, Jinying Zhang, Shenzhi Fang, et al.
Therapeutic Advances in Neurological Disorders|December 18, 2023
Clinical characteristics, treatments, and outcomes of interferon-beta-induced thrombotic microangiopathy: a literature-based retrospective analysisChunjiang Wang, Weijin Fang, Wei Sun, et al.
Therapeutic Advances in Neurological Disorders|December 28, 2023
Guideline for the management of myasthenic syndromesHeinz Wiendl, Angela Abicht, Andrew Chan, et al.
Therapeutic Advances in Neurological Disorders|November 29, 2023
A secondary daily persistent headache from onset with underlying nutcracker physiology and spinal epidural venous congestion: case series with lumbar vein embolization as a therapeutic approachTodd D Rozen, Zlatko Devcic, Andrew R Lewis, et al.
Therapeutic Advances in Neurological Disorders|November 29, 2023
The vascular locked-in and locked-in-plus syndrome: A retrospective case seriesLaura Schnetzer, Jürgen Steinbacher, Gerhard Bauer, et al.
Therapeutic Advances in Neurological Disorders|April 1, 2024
Serum neurofilament light chain correlations in patients with a first clinical demyelinating event in the REFLEX study: a post hoc analysisJens Kuhle, David Leppert, Giancarlo Comi, et al.
Therapeutic Advances in Neurological Disorders|April 3, 2024
Exploring the association between weight loss-inducing medications and multiple sclerosis: insights from the FDA adverse event reporting system databaseAfsaneh Shirani, Anne H Cross, Olaf Stuve
Therapeutic Advances in Neurological Disorders|March 18, 2024
Disease-modifying therapy initiation patterns in multiple sclerosis in three large MS populationsAlexander Stahmann, Elaine Craig, David Ellenberger, et al.
Therapeutic Advances in Neurological Disorders|April 1, 2024
Treatment switches of disease-modifying therapies in people with multiple sclerosis: long-term experience from the German MS RegistryNiklas Frahm, David Ellenberger, Alexander Stahmann, et al.
Therapeutic Advances in Neurological Disorders|September 25, 2024
Targeting dorsal root ganglia for chemotherapy-induced peripheral neuropathy: from bench to bedsideEliana Ege, Daniel Briggi, Peter Vu, et al.
Pageof 108